Medomics Combined Antigen Test Kit for Influenza and Novel 2019 New Virus
|
Still deciding? Get samples of $ !
Request Sample
|
Product Details
| Customization: | Available |
|---|---|
| Type: | IVD Reagent |
| Certificate: | ISO, CE |
Gold Member Since 2020
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Importers and Exporters
High Repeat Buyers Choice
Experienced Team
Exhibition Experience
The supplier has import and export rights
More than 50% of buyers repeatedly choose the supplier
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
Sign In to see all verified strength labels (26)
Find Similar Products
Basic Info.
- Model NO.
- Antigen Test
- Transport Package
- Box+Carton
- Trademark
- OBM/OEM
- Origin
- China
- HS Code
- 3002150090
- Production Capacity
- 5, 000, 000 Pieces/Month
Product Description
Medomics Flu A&B and Novel Virus Antigen Test Kit (LFIA) is used to qualitatively detect influenza virus type A, influenza virus typeB and novel virus antigens in human samples in vitro. 2019 Novel Virus belongs to the order Nidovirales under the Coronaviridae family with 4 genera: α, β, γ and δ. The α and β genera are only pathogenic to mammals, while γ and δ genera mainly causes bird infections.
Since Flu A&B and 2019 novel virus have similar symptoms and routes of infection, the kit has important clinical significance in identifying them.
Key Features:
Sensitivity: >95%
Specificity: 100%
Reaction Time: 10mins
Sample: nasopharyngeal swab specimens
Storage temperature: 4-30ºC
Sensitivity: >95%
Specificity: 100%
Reaction Time: 10mins
Sample: nasopharyngeal swab specimens
Storage temperature: 4-30ºC
About Medomics
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.
Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.
Contact Medomics
){kind=link}
Send your message to this supplier
People who viewed this also viewed
Product Groups
Find Similar Products By Category
- Supplier Homepage
- Products
- Virus Rapid Test Kit
- Flu and Antigen Combined Test
- Medomics Combined Antigen Test Kit for Influenza and Novel 2019 New Virus
Related Categories
Hot Searches
More